• S1 Episode 2: How to Optimize Treatment Timing in Bladder Cancer

  • 2022/07/06
  • 再生時間: 23 分
  • ポッドキャスト

S1 Episode 2: How to Optimize Treatment Timing in Bladder Cancer

  • サマリー

  • Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Multimodal Management of Muscle Invasive Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190161/

    Role of Immunotherapy in Localized Muscle Invasive Urothelial Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/

    Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795541/

    続きを読む 一部表示

あらすじ・解説

Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Multimodal Management of Muscle Invasive Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190161/

Role of Immunotherapy in Localized Muscle Invasive Urothelial Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795541/

S1 Episode 2: How to Optimize Treatment Timing in Bladder Cancerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。